All material subject to strictly enforced copyright laws. © 2022 IFLR is part of the Euromoney Institutional Investor PLC group.

DEAL: CVS’ proposed $69 billion acquisition of Aetna

The US pharmacy company has agreed a large breakup fee should the deal fall through, suggesting confidence that it will proceed unscathed

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login